In the Mix: 11 More Articles — March 24, 2026
In the Mix — Last 24 HoursMarch 24, 2026. 11 articles reviewed below the CED clinical relevance threshold of 35. Listed in descending order of score. #25Scientists Identify Protein That Slows Key Effects of Aging – SciTechDailyArticle Summary This…
New Research Highlights Cannabinoids’ Potential for Liver and Heart Health
Recent studies highlight cannabinoids hepatoprotective properties, especially CBD and CBG, in reducing liver inflammation and lipid accumulation. These findings suggest potential benefits for patients with fatty liver disease and metabolic syndrome.…
Cannabis Compound Shows Promise in Fighting Alzheimer’s by Calming Brain Inflammation
Cannabis compounds alzheimers research highlights potential to calm brain inflammation, a key factor in neurodegeneration. Emerging evidence suggests cannabinoids may modulate neuroinflammatory pathways involved in Alzheimer's disease. Clinicians should…
Age-Dependent Psychiatric Risks in Cannabis Use Disorder
Cannabis use disorder psychiatric risks are significantly higher in younger patients, requiring age-stratified clinical assessment. Early intervention is crucial to prevent serious mental illness progression. Clinicians must tailor counseling and…
New Research Reveals Age Plays Key Role in Cannabis‑Related Psychiatric Risks
Recent studies highlight age-dependent cannabis psychiatric risks, showing younger users face higher vulnerability to mental health issues. This research underscores the importance of age-specific clinical screening. Understanding these risks aids in…
Rethinking Cannabis and Its Effects on the Aging Brain
Understanding aging brain cannabis effects is crucial for clinicians treating older adults. Cannabis use among seniors is rising despite limited safety data. This article reviews key considerations for cognitive function and neurodegeneration in…
Scoop: Medicare CBD Pilot Will Allow Some THC in Products – Cannabis Wire
The Medicare CBD pilot program permits cannabidiol products containing trace THC, expanding access to cannabis-based treatments for eligible older adults. This policy shift could reduce out-of-pocket costs and improve medication adherence for seniors…
Cannabis Compounds May Reverse Fatty Liver Disease, Study Suggests – Science Alert
Emerging research highlights cannabinoid efficacy nonalcoholic fatty liver disease, focusing on CBD and CBG's potential benefits. These cannabinoids may regulate metabolism and reduce lipid accumulation in the liver. However, clinical trials are needed…
No ‘Next Day’ Impairment Caused by Cannabis – The Leaf Online
Recent research on no next day cannabis impairment offers new clinical insights. This focus keyword highlights findings about cannabis timing and safety. Understanding cannabis effects on daytime function is crucial for patient counseling.
Study Found CBD and CBG May Counter Fatty Liver Disease | Cannabis Sciences
Emerging research highlights hepatoprotective effects CBD CBG may provide in managing fatty liver disease. These cannabinoids show potential in reducing liver fat and improving function. Clinicians should consider this early evidence cautiously while…